West Caldwell, NJ, United States of America

Steve Yik-Kai Tam

This inventor holds 7 USPTO granted patents. Top assignees: Hoffmann-La Roche Inc., The United States of America. Active years: 1989-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steve Yik-Kai Tam. Retrieved from https://idiyas.com/inventor/steve-yik-kai-tam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 120(Granted Patents)

Company Filing History:

7 out of 5,026

Hoffmann-La Roche Inc.

patents

1 out of 255

The United States of America

patents

where one patent can have more than one assignee

Years Active: 1989-1998

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5780607 - Antisense oligomers (1998-07-14),

2. 5164376 - Method for treating retroviral infections with aryl-(2-pyrryl) keytone (1992-11-17),

3. 5141735 - Substituted amino-benzodiazepines having anitviral activity (1992-08-25),

4. 5126347 - Isomeric dideoxynuclesides (1992-06-30),

5. 5036101 - Method for treating retroviral infections with aryl-(2-pyrryl) ketone (1991-07-30),

6. 4900828 - Intermediate compounds and an improved procedure for the synthesis of (1990-02-13),

7. 4837311 - Anti-retroviral compounds (1989-06-06),

Title: The Innovative Contributions of Steve Yik-Kai Tam

Introduction

Steve Yik-Kai Tam is a notable inventor based in West Caldwell, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of antisense oligomers and methods for treating viral infections. With a total of 7 patents to his name, Tam's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents, Tam has developed antisense oligomers characterized by specific chemical formulas. These oligomers are designed to target and inhibit the expression of specific genes. Additionally, he has patented a method for treating retroviral infections using aryl-(2-pyrryl) ketone compounds. This innovative approach offers new possibilities for treating viral infections in patients.

Career Highlights

Throughout his career, Tam has worked with prominent organizations, including Hoffmann-La Roche Inc. and the United States of America. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Tam has had the opportunity to work alongside esteemed colleagues such as Ming-Chu Hsu and Manfred Weigele. These collaborations have further enriched his research and innovation efforts.

Conclusion

Steve Yik-Kai Tam's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence advancements in medical treatments and therapies.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]